07. February 2024 | Corporate News

Marinomed Biotech AG with important progress for Carragelose in 2024

  • First patient enrolled in clinical study investigating the moisturizing effectiveness of Carragelose eye drops
  • Clinical data showing the effectiveness of Carragelose in alleviating allergic symptoms in patients with grass pollen allergy published in peer-reviewed International Journal of General Medicine
  • Marinomed has received patents covering the decongestant Carragelose/Sorbitol combination in Singapore, South Korea, and Brazil

The full press release is available as download here:

Marinomed Biotech AG with important progress for Carragelose in 2024
(67 KB)